文献速递关节外科

重新评估血糖控制:基于糖化血红蛋白与当日血糖水平对全膝关节置换术患者90天主要并发症进行分层的新方法

Reassessing Glycemic Control: A Novel Method for 90-Day Major Complication Stratification Based on Hemoglobin A1c and Same-Day Glucose Levels for Patients Undergoing Total Knee Arthroplasty.
PubMed 文献 · J Arthroplasty · 2024-10-16

本研究通过分层特异性似然比分析,在全膝关节置换术(TKA)患者中确定了数据驱动的糖化血红蛋白(HbA1c)和当日血糖分层,并与90天主要并发症风险相关;各HbA1c分层及当日血糖≥190 mg/dL与主要并发症风险升高相关,但无分层与90天手术部位感染(SSI)风险显著相关。

要点

  • HbA1c分层为4.5-5.9%、6.0-6.4%、6.5-7.9%、8.0%以上,90天主要并发症风险随分层升高而递增。
  • 当日血糖≥190 mg/dL者较60-189 mg/dL者90天主要并发症风险升高(RR 1.18)。
  • 未发现任何HbA1c或当日血糖分层与90天SSI风险显著相关。

核心结论

  • 作者认为,既往文献采用的单一HbA1c截断值可能遗漏了风险分层的整体情况;当日血糖阈值可用于手术当日血糖控制指南,以进一步降低90天主要并发症风险。

研究设计与样本

  • 研究采用分层特异性似然比分析确定数据驱动的HbA1c和血糖分层,并将各分层基于年龄、性别、高血压、心力衰竭、慢性阻塞性肺疾病和肥胖与最低分层进行倾向评分匹配,分析各分层相对于最低匹配分层的并发症风险比(RR)。

主要发现

  • 与倾向评分匹配的最低分层(HbA1c 4.5-5.9%)相比,90天主要并发症风险随HbA1c分层升高而递增:6.0-6.4%(RR 1.23;P=0.024)、6.5-7.9%(RR 1.38;P<0.001)、8.0%以上(RR 2.0;P<0.001)。
  • 与倾向评分匹配的最低分层(当日血糖60-189 mg/dL)相比,当日血糖190 mg/dL以上分层90天主要并发症风险更高(RR 1.18;P=0.016)。
  • 没有任何HbA1c或当日血糖分层与90天SSI风险存在显著差异。

关键数值与推荐

  • 确定的HbA1c(%)分层为4.5-5.9、6.0-6.4、6.5-7.9和8.0以上,当日血糖(mg/dL)分层为60-189和190以上,用于预测90天主要并发症。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Glucose levels obtained on the day of surgery may be predictive of complications following total knee arthroplasty (TKA). Established glucose thresholds for TKA are either nonspecific or have low predictive power. Therefore, the purpose of this study was to create data-driven hemoglobin A1c (HbA1c) and same-day glucose thresholds associated with varying risks of 90-day major and surgical site infection (SSI) complications following TKA. METHODS: Stratum-specific likelihood ratio analysis was conducted to determine data-driven HbA1c and glucose strata associated with varying risks of 90-day major and SSI complications. Each strata was then propensity score matched to the lowest strata based on age, sex, hypertension, heart failure, chronic obstructive pulmonary disorder, and obesity. The risk ratio (RR) for complications in each stratum with respect to the lowest matched stratum was analyzed. RESULTS: Four data-driven HbA1c (%) strata (4.5 to 5.9, 6.0 to 6.4, 6.5 to 7.9, and 8.0+) and two same-day glucose (mg/dL) strata (60 to 189 and 190+) were identified that predicted 90-day major complications. When compared to the propensity-matched lowest strata (4.5 to 5.9%), the risk of 90-day major complications sequentially increased as the HbA1c (%) strata increased: 6.0 to 6.4 (RR: 1.23; P = 0.024), 6.5 to 7.9 (RR: 1.38; P < 0.001), and 8.0+ (RR: 2.0; P < 0.001). When compared to the propensity-matched lowest strata (60 to 189 mg/dL), the 190+ mg/dL strata had a higher risk of 90-day major complications (RR: 1.18; P = 0.016). No HbA1c or same-day glucose strata had significantly different risks of 90-day SSI. CONCLUSIONS: The multiple strata identified for HbA1c demonstrate that a single HbA1c cutoff as identified in prior literature may be missing a larger picture for risk stratification. The threshold identified for same-day glucose can be utilized in day-of-surgery glycemic control guidelines to further reduce the risk of 90-day major complications.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Gupta A, Liu IZ, Zhao AY, et al. Reassessing Glycemic Control: A Novel Method for 90-Day Major Complication Stratification Based on Hemoglobin A1c and Same-Day Glucose Levels for Patients Undergoing Total Knee Arthroplasty. J Arthroplasty. 2024. PMID: 39424241. doi:10.1016/j.arth.2024.10.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。